The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Regulatory News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.85
Bid: 1.80
Ask: 1.90
Change: 0.175 (10.45%)
Spread: 0.10 (5.556%)
Open: 1.75
High: 1.925
Low: 1.70
Prev. Close: 1.675
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Block Listing Returns

31 May 2023 07:00

RNS Number : 0413B
Genedrive PLC
31 May 2023
 

 

genedrive plc

("genedrive" or the "Company")

 

Block Listing Returns

 

The Company confirms the block listing six monthly return for the period to 31 May 2023.

 

Name of applicant

genedrive plc

 

Name of scheme

2007 Share Option Scheme

 

Period of return:

From:

01 December 2022

To:

 31 May 2023

Balance of unallocated securities under scheme(s) from previous return:

139,226 shares

 

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

7,500 shares

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

131,726 shares

 

 

In order to co-terminate future block listing returns the Company confirms the following returns for the two block listings granted earlier in the month.

 

Name of applicant

genedrive plc

 

Name of scheme

2017 Share Option Scheme

 

Period of return:

From:

19 May 2023

To:

 31 May 2023

Balance of unallocated securities under scheme(s) from previous return:

1,150,588 shares

 

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

Nil

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1,150,588 shares

 

 

Name of applicant

genedrive plc

 

Name of scheme

Unapproved Share Option Scheme

 

Period of return:

From:

19 May 2023

To:

 31 May 2023

Balance of unallocated securities under scheme(s) from previous return:

2,668,144 shares

 

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

Nil

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

2,668,144 shares

 

Name of contact:

Russ Shaw CFO

Telephone number of contact:

+44 (0)161 989 0245

 

For enquires:

 

genedrive plc

+44 (0)161 989 0245

David Budd: CEO / Russ Shaw: CFO

Peel Hunt LLP (Nominated Adviser and Joint Broker)

+44 (0)20 7418 8900

James Steel / Oliver Duckworth

finnCap (Joint Broker)

+44 (0)20 7220 500

Geoff Nash / George Dollemore / Nigel Birks / Alice Lane

Walbrook PR Ltd (Media Relations & Investor Relations)

+44 (0)20 7933 8780 or genedrive@walbrookpr.com

Paul McManus / Anna Dunphy

+44 (0)7980 541 893 / +44 (0)7876 741 001

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRFLFILETIIVIV
Date   Source Headline
6th Feb 20157:48 amRNSNotice of Interim Results
12th Jan 201512:19 pmRNSResult of AGM
6th Jan 20152:50 pmRNSDirector/PDMR Shareholding
18th Dec 20149:08 amRNSGrant of Options
15th Dec 20145:26 pmRNSNotice of AGM
24th Nov 201410:00 amRNSDirectorate Change
28th Oct 20147:01 amRNSSuccessful Completion of Genedrive Trials
28th Oct 20147:00 amRNSFinal Results
7th Oct 20147:00 amRNSNotice of Results
28th Jul 20149:56 amRNSAdditional Listing
22nd Jul 20147:05 amRNSPre Close Trading Update
22nd Jul 20147:00 amRNSCollaborative funding agreement with GHIF
9th May 20149:22 amRNSHolding(s) in Company
8th May 20145:14 pmRNSHolding(s) in Company
1st May 20144:37 pmRNSAdditional Listing
23rd Apr 20148:45 amRNSAdditional Listing
8th Apr 20146:21 pmRNSAdditional Listing
7th Apr 20144:44 pmRNSDirector/PDMR Shareholding
25th Mar 20147:00 amRNSHalf Yearly Report
17th Feb 20149:34 amRNSNotice of Results
3rd Feb 20143:26 pmRNSHolding(s) in Company
3rd Feb 20142:43 pmRNSHolding(s) in Company
27th Jan 20147:00 amRNSDirectorate Change
7th Jan 20142:12 pmRNSDirectors' Shareholdings
6th Jan 20144:33 pmRNSAdditional Listing
18th Dec 201312:46 pmRNSResult of AGM
18th Dec 20137:00 amRNSRe Agreement
16th Dec 20133:36 pmRNSAdditional Listing
3rd Dec 20131:30 pmRNSDirector/PDMR Shareholding
26th Nov 20134:27 pmRNSAdditional Listing
26th Nov 20137:00 amRNSAnnual Report & Accounts and Notice of AGM
22nd Oct 20137:00 amRNSFinal Results
11th Oct 20138:49 amRNSDirectorate Change
7th Oct 20138:29 amRNSDirector/PDMR Shareholding
1st Oct 20131:06 pmRNSPreliminary Results Date
9th Sep 20137:00 amRNSTrading Update
23rd Aug 20132:38 pmRNSHolding(s) in Company
8th Aug 20133:09 pmRNSHolding(s) in Company
8th Aug 20137:00 amRNSEPISTEM RECEIVES PRESTIGIOUS FP7 GRANT AWARD
1st Aug 20137:00 amRNSTrading Update
1st Jul 20134:04 pmRNSDirector/PDMR Shareholding
29th May 20133:29 pmRNSHolding(s) in Company
15th Apr 20131:39 pmRNSHolding(s) in Company
8th Apr 20134:08 pmRNSDirector/PDMR Shareholding
26th Mar 20137:01 amRNSSenior Executive Incentive Package
26th Mar 20137:00 amRNSHalf Yearly Report
1st Mar 201310:06 amRNSNotice of Results
22nd Feb 20139:13 amRNSAdditional Listing
20th Feb 20139:39 amRNSHolding(s) in Company
20th Feb 20139:35 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.